Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

South Korean Govt Seeks To Allow Foreigners To Run Hospitals In Move To Strengthen Health Care Industry

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Days after the South Korea Minister for Health, Welfare and Family Affiars emphasized the importance of further strengthening the country's health care industry, Minister of Strategy and Finance Yoon Jeung-Hyun told reporters that South Korea is moving to allow profit-seeking foreigners to run hospitals in certain free economic zones

You may also be interested in...



President Lee Nominates Competition-friendly Bureaucrat As New Health Minister

SEOUL - South Korea President Lee Myung-bak nominated a new minister of Health and Welfare in a partial cabinet shuffle Aug. 30, and his nominee is viewed as a market-oriented bureaucrat who could introduce foreign-friendly policies for Korea's healthcare market

President Lee Nominates Competition-friendly Bureaucrat As New Health Minister

SEOUL - South Korea President Lee Myung-bak nominated a new minister of Health and Welfare in a partial cabinet shuffle Aug. 30, and his nominee is viewed as a market-oriented bureaucrat who could introduce foreign-friendly policies for Korea's healthcare market

Rising Wealth In China Spurs Demand For Cosmetic Plastic Surgery, Mostly Among Younger Women

HONG KONG - One of the fastest-growing pharmaceutical segments in China is plastic surgery

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071275

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel